NCT04721353View on ClinicalTrials.gov

Reducing Cannabis Overuse With Prazosin

PHASE4CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

November 9, 2020

Primary Completion Date

December 31, 2024

Study Completion Date

June 1, 2025

Conditions
Cannabis DependencePosttraumatic Stress DisorderCannabis Use Disorder
Interventions
DRUG

Prazosin Hydrochloride

prazosin hydrochloride oral 1-25 mg/day

Trial Locations (1)

98108

VA Puget Sound Health Care System, Seattle

All Listed Sponsors
collaborator

University of Washington

OTHER

collaborator

VA Mental Illness Research, Education and Clinical Centers

FED

lead

VA Puget Sound Health Care System

FED

NCT04721353 - Reducing Cannabis Overuse With Prazosin | Biotech Hunter | Biotech Hunter